Table 1.

Baseline patient characteristics

	Population (n=2145)
Demographics
__first allogeneic transplant, % (n)	80% (1712)
__age in years, mean (sd)	51 (13.3)
__female, % (n)	42% (894)
__white, % (n)	90% (1833)
Comorbidity Index, % (n)
__HCT-CI score 0	13% (276)
__HCT-CI score 1–2	25% (543)
__HCT-CI score >2	45% (966)
__missing	17% (360)
Disease Type, % (n)
__myeloid	61% (1299)
__lymphoid	36% (770)
__non-malignant	4% (75)
Donor Match, % (n)
__matched related (MRD)	31% (674)
__matched unrelated (MUD)	42% (907)
__mismatched related (MMRD)	6% (129)
__mismatched unrelated (MMUD)	12% (250)
__umbilical cord blood (UCB)	9% (185)
Conditioning Regimen, % (n)
__non-myeloablative (reduced intensity)	42% (909)
__myeloablative without high-dose TBI	41% (883)
__myeloablative with high-dose TBI (≧1200 cGy)	16% (353)
GVHD Prophylaxis, % (n)
__tacrolimus +	53% (1136)
__cyclosporine +	39% (838)
__sirolimus + tacrolimus or cyclosporine	6% (133)
__cyclophosphamide	2% (38)